Estelle Berreur obtained her Master's degree in Pharmacology and Toxicology at the University of Strasbourg, France in 2022. Her master's thesis project was performed at Roche, Basel. She started her PhD at Roche, Basel in January 2023 in the Pathology and Applied Safety Science group and the Precision Safety group under the guidance of Prof. Dr. Adrian Roth, and in collaboration with the Molecular & Systems Toxicology group  (academic supervision Prof. Dr. Alex Odermatt). Estelle’s research project focuses on the establishment of a liver model for safety assessment of AAV-based gene therapies.